Ginsenoside F2

Product Specifications

CAS Number

62025-49-4

Target

Endogenous Metabolite|||Apoptosis|||Autophagy

Related Pathways

Apoptosis|||Metabolism|||Autophagy

Purity

0.993

Bioactivity

Ginsenoside F2 has antiproliferative activity against breast cancer stem cells (CSCs) . It induces apoptosis in breast CSCs by activating the intrinsic apoptotic pathway and mitochondrial dysfunction.

Smiles

[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@](C)(CCC=C(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O